Scientists test copycat psoriasis drug in healthy volunteers
NCT ID NCT07254325
Summary
This early-stage study aims to see how a new version of a psoriasis drug (CMAB015) compares to an existing drug (Cosentyx) in healthy men. Researchers will give a single injection to 114 participants and track how their bodies process the drug and check for side effects over 16 weeks. The goal is to gather basic safety and drug-level data before testing in people with psoriasis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.